Literature DB >> 17178817

Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease.

Ashley J Hood1, Silvia C Amador, Ashley E Cain, Kevin A Briand, Ali H Al-Refai, Mya C Schiess, Anne B Sereno.   

Abstract

BACKGROUND: The integrity of frontal systems responsible for voluntary control and their interaction with subcortical regions involved in reflexive responses were studied in patients with Parkinson's disease (PD). Previous studies have shown that patients with PD have impaired executive function, including deficits in attention, motor planning and decision making.
METHODS: Executive function was measured through eye movements: reflexive (stimulus driven) prosaccades and voluntary (internally guided) antisaccades. Patients with advanced idiopathic PD, off and on their optimal levodopa therapy, were tested on a prosaccade and an antisaccade task and compared with matched controls.
RESULTS: Levodopa significantly increased response time for reflexive prosaccades and reduced error rate for voluntary antisaccades.
CONCLUSIONS: Consistent with our proposed model, patients with PD in the medicated state are better able to plan and execute voluntary eye movements. These findings suggest levodopa improves function of the voluntary frontostriatal system, which is deficient in PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178817      PMCID: PMC2077956          DOI: 10.1136/jnnp.2006.099754

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  Control of voluntary and reflexive saccades in Parkinson's disease.

Authors:  K A Briand; D Strallow; W Hening; H Poizner; A B Sereno
Journal:  Exp Brain Res       Date:  1999-11       Impact factor: 1.972

Review 2.  Using saccades as a research tool in the clinical neurosciences.

Authors:  R J Leigh; Christopher Kennard
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

3.  Functional organization of human intraparietal and frontal cortex for attending, looking, and pointing.

Authors:  Serguei V Astafiev; Gordon L Shulman; Christine M Stanley; Abraham Z Snyder; David C Van Essen; Maurizio Corbetta
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

4.  Disturbed striatoprefrontal mediated visual behaviour in moderate to severe parkinsonian patients.

Authors:  L Crevits; K De Ridder
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

5.  Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients.

Authors:  Silvia C Amador; Ashley J Hood; Mya C Schiess; Robert Izor; Anne B Sereno
Journal:  Neuropsychologia       Date:  2005-12-22       Impact factor: 3.139

6.  Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects.

Authors:  M Jahanshahi; I H Jenkins; R G Brown; C D Marsden; R E Passingham; D J Brooks
Journal:  Brain       Date:  1995-08       Impact factor: 13.501

7.  Sequences of memory-guided saccades in Parkinson's disease.

Authors:  A I Vermersch; S Rivaud; M Vidailhet; A M Bonnet; B Gaymard; Y Agid; C Pierrot-Deseilligny
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

8.  Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism.

Authors:  N J Minshew; B Luna; J A Sweeney
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

Review 9.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

Authors:  E D Playford; I H Jenkins; R E Passingham; J Nutt; R S Frackowiak; D J Brooks
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

View more
  41 in total

1.  Visual exploration of emotional facial expressions in Parkinson's disease.

Authors:  Uraina S Clark; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2010-03-15       Impact factor: 3.139

2.  Multiple step pattern as a biomarker in Parkinson disease.

Authors:  Tanya Blekher; Marjorie Weaver; Jason Rupp; William C Nichols; Siu L Hui; Jacqueline Gray; Robert D Yee; Joanne Wojcieszek; Tatiana Foroud
Journal:  Parkinsonism Relat Disord       Date:  2009-02-10       Impact factor: 4.891

3.  Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.

Authors:  Anne Schmechtig; Jane Lees; Lois Grayson; Kevin J Craig; Rukiya Dadhiwala; Gerard R Dawson; J F William Deakin; Colin T Dourish; Ivan Koychev; Katrina McMullen; Ellen M Migo; Charlotte Perry; Lawrence Wilkinson; Robin Morris; Steve C R Williams; Ulrich Ettinger
Journal:  Psychopharmacology (Berl)       Date:  2013-02-22       Impact factor: 4.530

4.  Constraining eye movement in individuals with Parkinson's disease during walking turns.

Authors:  V N Pradeep Ambati; Fabricio Saucedo; Nicholas G Murray; Douglas W Powell; Rebecca J Reed-Jones
Journal:  Exp Brain Res       Date:  2016-06-20       Impact factor: 1.972

5.  Dorsal striatum mediates deliberate decision making, not late-stage, stimulus-response learning.

Authors:  Nole M Hiebert; Adrian M Owen; Ken N Seergobin; Penny A MacDonald
Journal:  Hum Brain Mapp       Date:  2017-09-25       Impact factor: 5.038

6.  The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease.

Authors:  Lisa C Goelz; Fabian J David; John A Sweeney; David E Vaillancourt; Howard Poizner; Leonard Verhagen Metman; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2016-11-14       Impact factor: 1.972

7.  Impaired control of the oculomotor reflexes in Parkinson's disease.

Authors:  Martijn G van Koningsbruggen; Tom Pender; Liana Machado; Robert D Rafal
Journal:  Neuropsychologia       Date:  2009-06-26       Impact factor: 3.139

8.  Remedial effects of motivational incentive on declining cognitive control in healthy aging and Parkinson's disease.

Authors:  Helga A Harsay; Jessika I V Buitenweg; Jasper G Wijnen; Maria J S Guerreiro; K Richard Ridderinkhof
Journal:  Front Aging Neurosci       Date:  2010-10-15       Impact factor: 5.750

9.  Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.

Authors:  Elmar H Pinkhardt; Reinhart Jürgens; Wolfgang Becker; Federica Valdarno; Albert C Ludolph; Jan Kassubek
Journal:  J Neurol       Date:  2009-01-14       Impact factor: 4.849

10.  Pallidal Deep Brain Stimulation Improves Higher Control of the Oculomotor System in Parkinson's Disease.

Authors:  Chrystalina A Antoniades; Pedro Rebelo; Christopher Kennard; Tipu Z Aziz; Alexander L Green; James J FitzGerald
Journal:  J Neurosci       Date:  2015-09-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.